SE0000537L - Användning av en förening för framställning av ett läkemedel - Google Patents

Användning av en förening för framställning av ett läkemedel

Info

Publication number
SE0000537L
SE0000537L SE0000537A SE0000537A SE0000537L SE 0000537 L SE0000537 L SE 0000537L SE 0000537 A SE0000537 A SE 0000537A SE 0000537 A SE0000537 A SE 0000537A SE 0000537 L SE0000537 L SE 0000537L
Authority
SE
Sweden
Prior art keywords
group
lower alkyl
iodine
compound
carbon atoms
Prior art date
Application number
SE0000537A
Other languages
English (en)
Other versions
SE516067C2 (sv
SE0000537D0 (sv
Inventor
Lennart Moeller
Jan Bergman
Original Assignee
Lundblad Leif J I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundblad Leif J I filed Critical Lundblad Leif J I
Priority to SE0000537A priority Critical patent/SE516067C2/sv
Publication of SE0000537D0 publication Critical patent/SE0000537D0/sv
Priority to AU2001236266A priority patent/AU2001236266B2/en
Priority to EP01908522A priority patent/EP1261344B1/en
Priority to RU2002124771/15A priority patent/RU2266117C2/ru
Priority to JP2001559467A priority patent/JP2003522792A/ja
Priority to AU3626601A priority patent/AU3626601A/xx
Priority to CNB018052045A priority patent/CN1192777C/zh
Priority to DE60103857T priority patent/DE60103857T2/de
Priority to CA002400236A priority patent/CA2400236C/en
Priority to ES01908522T priority patent/ES2222981T3/es
Priority to HU0204547A priority patent/HUP0204547A3/hu
Priority to AT01908522T priority patent/ATE269083T1/de
Priority to PCT/SE2001/000326 priority patent/WO2001060371A1/en
Publication of SE0000537L publication Critical patent/SE0000537L/sv
Publication of SE516067C2 publication Critical patent/SE516067C2/sv
Priority to NO20023892A priority patent/NO323783B1/no
Priority to ZA200206733A priority patent/ZA200206733B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE0000537A 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel SE516067C2 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE0000537A SE516067C2 (sv) 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel
PCT/SE2001/000326 WO2001060371A1 (en) 2000-02-18 2001-02-16 Use of a compound for preparing a drug
CNB018052045A CN1192777C (zh) 2000-02-18 2001-02-16 吲哚并喹喔啉类化合物用于制备治疗多发性硬化症的药物的用途
CA002400236A CA2400236C (en) 2000-02-18 2001-02-16 Use of indoloquinoxaline derivatives for preparing a drug for the treatment of multiple sclerosis
RU2002124771/15A RU2266117C2 (ru) 2000-02-18 2001-02-16 Применение соединения для получения лекарственного препарата
JP2001559467A JP2003522792A (ja) 2000-02-18 2001-02-16 薬剤調製用化合物の用途
AU3626601A AU3626601A (en) 2000-02-18 2001-02-16 Use of a compound for preparing a drug
AU2001236266A AU2001236266B2 (en) 2000-02-18 2001-02-16 Use of a compound for preparing a drug
DE60103857T DE60103857T2 (de) 2000-02-18 2001-02-16 Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose
EP01908522A EP1261344B1 (en) 2000-02-18 2001-02-16 Use of indoloquinoxalines for the treatment of multiple sklerosis
ES01908522T ES2222981T3 (es) 2000-02-18 2001-02-16 Uso de indoloquinoxalinas para el tratamiento de esclerosis multiple.
HU0204547A HUP0204547A3 (en) 2000-02-18 2001-02-16 Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms
AT01908522T ATE269083T1 (de) 2000-02-18 2001-02-16 Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose
NO20023892A NO323783B1 (no) 2000-02-18 2002-08-16 Anvendelse av en forbindelse for fremstilling av et medikament
ZA200206733A ZA200206733B (en) 2000-02-18 2002-08-22 Use of a compound for preparing a drug.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000537A SE516067C2 (sv) 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel

Publications (3)

Publication Number Publication Date
SE0000537D0 SE0000537D0 (sv) 2000-02-18
SE0000537L true SE0000537L (sv) 2001-08-19
SE516067C2 SE516067C2 (sv) 2001-11-12

Family

ID=20278504

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000537A SE516067C2 (sv) 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel

Country Status (14)

Country Link
EP (1) EP1261344B1 (sv)
JP (1) JP2003522792A (sv)
CN (1) CN1192777C (sv)
AT (1) ATE269083T1 (sv)
AU (2) AU3626601A (sv)
CA (1) CA2400236C (sv)
DE (1) DE60103857T2 (sv)
ES (1) ES2222981T3 (sv)
HU (1) HUP0204547A3 (sv)
NO (1) NO323783B1 (sv)
RU (1) RU2266117C2 (sv)
SE (1) SE516067C2 (sv)
WO (1) WO2001060371A1 (sv)
ZA (1) ZA200206733B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE527639C2 (sv) 2004-06-17 2006-05-02 Oxypharma Ab Alkylsubstituerade indolokinoxaliner
DE602008001795D1 (de) 2008-04-30 2010-08-26 Univ Duisburg Essen IndolÄ2,3-bÜ-, IndenÄ1,2-bÜ- und IndenÄ2,1-bÜpyridoÄ2,3-fÜ Quinoxalin-3-Carboxylsäuren und Ester, Verfahren zu ihrer Herstellung und ihre Verwendung als Antivirus- und Antitumormittel
KR20230022880A (ko) 2020-06-10 2023-02-16 사익손 아베 라벡시모드의 결정성 형태를 포함하는 경구 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600260D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Substituerade indolokinoxaliner
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis

Also Published As

Publication number Publication date
CA2400236C (en) 2009-09-22
JP2003522792A (ja) 2003-07-29
ES2222981T3 (es) 2005-02-16
HUP0204547A3 (en) 2006-01-30
CN1192777C (zh) 2005-03-16
NO323783B1 (no) 2007-07-09
HUP0204547A2 (hu) 2003-04-28
ATE269083T1 (de) 2004-07-15
EP1261344A1 (en) 2002-12-04
CN1404393A (zh) 2003-03-19
SE516067C2 (sv) 2001-11-12
WO2001060371A1 (en) 2001-08-23
DE60103857T2 (de) 2005-07-14
NO20023892L (no) 2002-08-16
RU2002124771A (ru) 2004-03-10
ZA200206733B (en) 2003-08-22
RU2266117C2 (ru) 2005-12-20
CA2400236A1 (en) 2001-08-23
AU2001236266B2 (en) 2005-03-17
DE60103857D1 (de) 2004-07-22
EP1261344B1 (en) 2004-06-16
NO20023892D0 (no) 2002-08-16
SE0000537D0 (sv) 2000-02-18
AU3626601A (en) 2001-08-27

Similar Documents

Publication Publication Date Title
HUP0002112A2 (hu) Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
HUP9802822A2 (hu) Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények
NZ518144A (en) Piperazine Compounds
NZ506574A (en) Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism
IL160769A (en) Heterocyclic compounds and pharmaceutical compositions containing the same
SE8600260D0 (sv) Substituerade indolokinoxaliner
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
EP0409406A3 (en) Aryl-substituted amine derivatives useful in cancer therapy
HUT46313A (en) Process for producing 3/2h/-pyridazine derivatives and pharmaceutical compositions containing them as active components
MY117783A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
NZ332823A (en) ,5-Diimino-3a,6a-diaryl-1,2,3,3a,4,5,6,6a-octahydroimi dazo[4,5-d]imidazoles as non-peptide G-CSF mimetics
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
SE0000537L (sv) Användning av en förening för framställning av ett läkemedel
MXPA04005077A (es) Derivados de benzotiazol.
ATE207058T1 (de) Amine derivate, ihre herstellung und anwendung
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
TW259785B (en) Chemical compounds
MY141374A (en) Water soluble camptothecin derivatives
GR3023373T3 (en) Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
MXPA04002838A (es) Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
SE9900677D0 (sv) Agent for use in transplantation
IL112344A (en) Pharmaceutical compositions comprising 7, 9, 9-trisubstituted- 3-benzoyl-3, 7-diazabicyclo £3.3.1| nonanes for the treatment of cardiac arrhythmias
FI954213A0 (sv) Tumörmotverkande kompositioner och behandlingsmetoder
EA199700299A1 (ru) Азольные соединения с противогрибковой (антимикозной) активностью, применяемые для лечения людей и в ветеринарии

Legal Events

Date Code Title Description
NUG Patent has lapsed